Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) Director William D. Waddill sold 8,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $35.00, for a total transaction of $280,000.00. Following the completion of the transaction, the director now directly owns 12,000 shares […]
Gratus Capital LLC Has $9.12 Million Stock Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reiterates Buy Rating for Protagonist Therapeutics (NASDAQ:PTGX) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
E Fund Management Co. Ltd. Sells 9,034 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Protagonist Therapeutics (NASDAQ:PTGX) Shares Gap Up on Analyst Upgrade dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.